0001127602-22-005441.txt : 20220217
0001127602-22-005441.hdr.sgml : 20220217
20220217112257
ACCESSION NUMBER: 0001127602-22-005441
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220215
FILED AS OF DATE: 20220217
DATE AS OF CHANGE: 20220217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WELTZIEN LOURDES
CENTRAL INDEX KEY: 0001201184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14902
FILM NUMBER: 22646337
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC
CENTRAL INDEX KEY: 0000794172
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 310888197
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 3471 RIVER HILLS DR
CITY: CINCINNATI
STATE: OH
ZIP: 45244
BUSINESS PHONE: 5132713700
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
FORMER COMPANY:
FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-15
0000794172
MERIDIAN BIOSCIENCE INC
VIVO
0001201184
WELTZIEN LOURDES
3471 RIVER HILLS DRIVE
CINCINNATI
OH
45244
1
EVP, Life Science
Common Stock
2022-02-15
4
M
0
12500
14.65
A
95548
D
Common Stock
2022-02-15
4
M
0
7500
14.30
A
103048
D
Common Stock
2022-02-15
4
S
0
20000
25.5956
D
83048
D
Stock Options (Right to Buy)
14.65
2022-02-15
4
M
0
12500
0
D
2027-11-08
Common Stock
12500
0
D
Stock Options (Right to Buy)
14.30
2022-02-15
4
M
0
7500
0
D
2028-04-24
Common Stock
7500
2500
D
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $25.29 to $26.07. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
These non-qualified options were awarded under the 2012 Stock Incentive Plan and cliff vested in full on November 15, 2021.
These options were awarded under the 2012 Stock Incentive Plan and vest in four equal installments from the date of grant until fully vested on April 24, 2022.
/s/ F. Mark Reuter as Attorney-in-Fact for Lourdes G. Weltzien
2022-02-17